PUTRAJAYA: Malaysia has signed an agreement with Merck Sharp & Dohme (MSD) to procure antiviral medicine Molnupiravir for Covid-19 treatment.
Health Minister Khairy Jamaluddin said the government signed a letter of undertaking on Thursday (Oct 7) to procure 150,000 courses of Molnupiravir to treat Covid-19 patients.
Already a subscriber? Log in.
Save 30% and win Bosch appliances! More Info
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
